Page 189 - Haematologica May 2020

Intronic deletion in MKL1 alters B-cell function
Foundation to HB and LSW, the Swedish Cancer Society to MB and LSW, as well as the Swedish Research Council, the Swedish Childhood Cancer Fund, Karolinska Institutet, the European
Commission 7th Framework Program, Åke Olsson Foundation, Jeansson Foundation, and Bergvall Foundation to LSW. LSW is a Ragnar Söderberg Fellow in Medicine.
References
1. Borchmann S, Engert A. The genetics of Hodgkin lymphoma: an overview and clini- cal implications. Curr Opin Oncol. 2017;29(5):307-314.
2. Goldin LR, Bjorkholm M, Kristinsson SY, et al. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009;146(1):91-94.
3. Kanzler H, Kuppers R, Hansmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med. 1996;184(4):1495-1505.
4. Martin-Subero JI, Klapper W, Sotnikova A, et al. Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classi- cal Hodgkin lymphoma. Cancer Res. 2006;66(21):10332-10338.
5. Bechtel D, Kurth J, Unkel C, et al. Transformation of BCR-deficient germinal- center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas. Blood. 2005;106(13):4345-4350.
6. Mancao C, Altmann M, Jungnickel B, et al. Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus. Blood. 2005;106(13):4339-4344.
7. Wang DZ, Li S, Hockemeyer D, et al. Potentiation of serum response factor activi- ty by a family of myocardin-related tran- scription factors. Proc Natl Acad Sci U S A. 2002;99(23):14855-14860.
8. Miralles F, Posern G, Zaromytidou AI, et al. Actin dynamics control SRF activity by reg- ulation of its coactivator MAL. Cell. 2003;113(3):329-342.
9. Cen B, Selvaraj A, Burgess RC, et al. Megakaryoblastic leukemia 1, a potent tran- scriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes. Mol Cell Biol. 2003;23(18):6597-6608.
10. Selvaraj A, Prywes R. Expression profiling of serum inducible genes identifies a subset of SRF target genes that are MKL dependent. BMC Mol Biol. 2004;5:13.
11. Spencer JA, Misra RP. Expression of the serum response factor gene is regulated by serum response factor binding sites. J Biol Chem. 1996;271(28):16535-16543.
12. Hermann MR, Jakobson M, Colo GP, et al. Integrins synergise to induce expression of the MRTF-A-SRF target gene ISG15 for pro- moting cancer cell invasion. J Cell Sci. 2016;129(7):1391-1403.
13. Ma Z, Morris SW, Valentine V, et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblas- tic leukemia. Nat Genet. 2001;28(3):220-221.
14. Mercher T, Coniat MB, Monni R, et al. Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia. Proc Natl Acad Sci U S A. 2001;98(10):5776-5779.
15. Medjkane S, Perez-Sanchez C, Gaggioli C,
et al. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol. 2009;11(3):257-268.
16. Muehlich S, Hampl V, Khalid S, et al. The transcriptional coactivators megakaryoblas- tic leukemia 1/2 mediate the effects of loss of the tumor suppressor deleted in liver can- cer 1. Oncogene. 2012;31(35):3913-3923.
17. Evelyn CR, Wade SM, Wang Q, et al. CCG- 1423: a small-molecule inhibitor of RhoA transcriptional signaling. Mol Cancer Ther. 2007;6(8):2249-2260.
18. Hayashi K, Watanabe B, Nakagawa Y, et al. RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling. PLoS One. 2014;9(2):e89016.
19. Record J, Malinova D, Zenner HL, et al. Immunodeficiency and severe susceptibility to bacterial infection associated with a loss- of-function homozygous mutation of MKL1. Blood. 2015;126(13):1527-1535.
20. Bjorkholm M, Sjoberg J, Nygell UA, et al. Development of Hodgkin lymphoma in homozygotic triplets with constitutional deletion in MKL1. Blood. 2013;121(23):4807.
21. Nagy N, Adori M, Rasul A, et al. Soluble fac- tors produced by activated CD4+ T cells modulate EBV latency. Proc Natl Acad Sci U S A. 2012;109(5):1512-1517.
22. Patarroyo M, Beatty PG, Nilsson K, Gahmberg CG. Identification of a cell-sur- face glycoprotein mediating cell adhesion in EBV-immortalized normal B cells. Int J Cancer. 1986;38(4):539-547.
23. Gronberg A, Halapi E, Ferm M, Petersson M, Patarroyo M. Regulation of lymphocyte aggregation and proliferation through adhe- sion molecule CD54 (ICAM-1). Cell Immunol. 1993;147(1):12-24.
24. Rothlein R, Springer TA. The requirement for lymphocyte function-associated antigen 1 in homotypic leukocyte adhesion stimu- lated by phorbol ester. J Exp Med. 1986;163(5):1132-1149.
25. Merk K, Bjorkholm M, Tullgren O, Mellstedt H, Holm G. Immune deficiency in family members of patients with Hodgkin's dis- ease. Cancer. 1990;66(9):1938-1943.
26. Bjorkholm M, Holm G, Mellstedt H. Persisting lymphocyte deficiences during remission in Hodgkin's disease. Clin Exp Immunol. 1977;28(3):389-393.
27. Marits P, Wikstrom AC, Popadic D, Winqvist O, Thunberg S. Evaluation of T and B lymphocyte function in clinical prac- tice using a flow cytometry based prolifera- tion assay. Clin Immunol. 2014;153(2):332- 342.
28. Shumilov A, Tsai MH, Schlosser YT, et al. Epstein-Barr virus particles induce centro- some amplification and chromosomal insta- bility. Nat Commun. 2017;8:14257.
29. Wolf J, Kapp U, Bohlen H, et al. Peripheral blood mononuclear cells of a patient with advanced Hodgkin's lymphoma give rise to permanently growing Hodgkin-Reed Sternberg cells. Blood. 1996;87(8):3418- 3428.
30. Verrills NM, Liem NL, Liaw TY, Hood BD, Lock RB, Kavallaris M. Proteomic analysis reveals a novel role for the actin cytoskele-
ton in vincristine resistant childhood leukemia--an in vivo study. Proteomics. 2006;6(5):1681-1694.
31. Rath N, Olson MF. Rho-associated kinases in tumorigenesis: re-considering ROCK inhi- bition for cancer therapy. EMBO Rep. 2012;13(10):900-908.
32. Gilles L, Bluteau D, Boukour S, et al. MAL/SRF complex is involved in platelet formation and megakaryocyte migration by regulating MYL9 (MLC2) and MMP9. Blood. 2009;114(19):4221-4232.
33. Smith EC, Thon JN, Devine MT, et al. MKL1 and MKL2 play redundant and cru- cial roles in megakaryocyte maturation and platelet formation. Blood. 2012;120 (11):2317-2329.
34. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144 (5):646-674.
35. Dorner M, Zucol F, Berger C, et al. Distinct ex vivo susceptibility of B-cell subsets to epstein-barr virus infection according to dif- ferentiation status and tissue origin. J Virol. 2008;82(9):4400-4412.
36. Heath E, Begue-Pastor N, Chaganti S, et al. Epstein-Barr virus infection of naive B cells in vitro frequently selects clones with mutat- ed immunoglobulin genotypes: implications for virus biology. PLoS Pathog. 2012;8(5):e1002697.
37. Huang GL, Li BK, Zhang MY, et al. Allele loss and down-regulation of heparanase gene are associated with the progression and poor prognosis of hepatocellular carcinoma. PLoS One. 2012;7(8):e44061.
38. Shaul O. How introns enhance gene expres- sion. Int J Biochem Cell Biol. 2017;91(Pt B):145-155.
39. Baarlink C, Wang H, Grosse R. Nuclear actin network assembly by formins regulates the SRF coactivator MAL. Science. 2013;340(6134):864-867.
40. Cheng X, Yang Y, Fan Z, et al. MKL1 poten- tiates lung cancer cell migration and inva- sion by epigenetically activating MMP9 transcription. Oncogene. 2015;34(44):5570- 5581.
41. Hu Q, Guo C, Li Y, Aronow BJ, Zhang J. LMO7 mediates cell-specific activation of the Rho-myocardin-related transcription factor-serum response factor pathway and plays an important role in breast cancer cell migration. Mol Cell Biol. 2011;31(16):3223- 3240.
42. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta. 2007;1773(5):642-652.
43. Hamidi H, Pietila M, Ivaska J. The complex- ity of integrins in cancer and new scopes for therapeutic targeting. Br J Cancer. 2016;115(9):1017-1023.
44. Nguyen HG, Ravid K. Polyploidy: mecha- nisms and cancer promotion in hematopoi- etic and other cells. Adv Exp Med Biol. 2010;676:105-122.
45. Moulding DA, Moeendarbary E, Valon L, Record J, Charras GT, Thrasher AJ. Excess F- actin mechanically impedes mitosis leading to cytokinesis failure in X-linked neutrope- nia by exceeding Aurora B kinase error cor-
haematologica | 2020; 105(5)
1349